Clinical trials: Electrical Cardioversion
Atrial Fibrillation, Atrial Flutter
Left Atrial Thrombus on Transesophageal Echocardiography
The aim of the study is to assess the prevalence of left atrial thrombus in patients with atrial fibrillation (AF) or atrial flutter (AFI), in whom transesophageal echocardiography is performed before AF/AFl cardioversion or…
- Conditions
- Atrial Fibrillation, Atrial Flutter, Transesophageal Echocardiography, Ablation
- Trial name
- LATTEE (NCT03591627)
- Testing
- Transesophageal echocardiography
- Where
- Poland
- Volunteers
- 200 people
- Sponsor
- Medical University of Warsaw
Stroke, Transient Ischemic Attacks
Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study)
The aim of this study is to evaluate the role of atrial fibrillation (AF) and its treatment in relation to thromboembolic events (stroke, and transient ischemic attacks) and intracranial hemorrhage.
- Conditions
- Stroke, Transient Ischemic Attacks, Intracranial Hemorrhage, Atrial Fibrillation
- Trial name
- FibStroke (NCT02146040)
- Where
- 4 sites in Finland
- Volunteers
- 5,885 people
- Sponsor
- University of Turku
Atrial Fibrillation
Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
Atrial fibrillation (AF) is the most common type of irregular heartbeat in emergency department (ED) patients. If the irregular heartbeat has been present for less than 48 hours, there is a chance that emergency treatment can…
- Trial name
- NCT01994070
- Testing
- Electrical-first, Chemical-first
- Where
- Canada
- Volunteers
- 86 people
- Sponsor
- University of British Columbia
Atrial Fibrillation, Heart Failure
The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
The purpose of this study is to evaluate the efficacy of ranolazine in the prevention of recurrent atrial fibrillation in post-cardioversion patients with heart failure and preserved ejection fraction.
- Trial name
- RAD HF (NCT01887353)
- Testing
- Ranolazine
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Intermountain Health Care, Inc.
Persistent Atrial Fibrillation
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
- Trial name
- ReMATCH (NCT06735534)
- Testing
- FARAPULSE™ Pulsed Field Ablation System
- Where
- 41 sites in United States, Australia and 1 more
- Volunteers
- 376 people
- Sponsor
- Boston Scientific Corporation
Atrial Fibrillation
Device-based Rate Versus Rhythm Control in Symptomatic Recent-onset Atrial Fibrillation (RACE 9 OBSERVE-AF)
Continuous heart rhythm monitoring elucidated the recurrent and transient nature of recent-onset atrial fibrillation (AF). The RACE7 ACWAS showed that a wait-and-see approach (WAS) in patients with recent-onset AF (rate control…
- Trial name
- NCT04612335
- Testing
- Rate control, Pharmacological or electrical cardioversion
- Where
- 14 sites in Netherlands
- Volunteers
- 490 people
- Sponsor
- Maastricht University Medical Center
Atrial Fibrillation
QT Variability Pre and Post Cardioversion
The purpose of this study is to learn whether the chemicals in the blood and urine are different when the heart is atrial fibrillation compared to normal sinus rhythm.
- Trial name
- DCCV (NCT00885391)
- Where
- United States
- Volunteers
- 219 people
- Sponsor
- Vanderbilt University
Atrial Fibrillation Fluttering
Ankle - Brachial Index Measurement in Atrial Fibrillation
Consecutive patients with atrial fibrillation will be admitted to the hospital for electrical cardioversion. Ankle brachial index will be measured three times with oscillometric method and three times with doppler method.
- Trial name
- AFABI (NCT02986282)
- Testing
- ABI measurement using both doppler and oscillometric method
- Volunteers
- 115 people
- Sponsor
- Medical University of Warsaw
Atrial Fibrillation, Renal Insufficiency
Renal Function Post Cardioversion for Atrial Fibrillation
Atrial fibrillation is a common arrhythmia which requires electrical cardioversion in many patients in order to regain sinus rhythm.
- Conditions
- Atrial Fibrillation, Renal Insufficiency, Cardioversion
- Trial name
- AFCARD-II (NCT02742207)
- Testing
- Electrical atrial fibrillation Cardioversion, Cardioversion
- Where
- Israel
- Volunteers
- 150 people
- Sponsor
- Hadassah Medical Organization
Atrial Fibrillation
Safety of Cardioversion of Acute Atrial Fibrillation
The purpose of this study is to investigate the complications of cardioversion of acute (<48 hours duration) atrial fibrillation (AF).
- Trial name
- FinCV (NCT01380574)
- Where
- 3 sites in Finland
- Volunteers
- 7,700 people
- Sponsor
- Turku University Hospital
Atrial Fibrillation (AF)
Cardiac Stunning After Electrical Cardioversion
The goal of this observational study is to evaluate cardiac stunning and electrocardiographic parameters through transthoracic echocardiography and 24 hours ECG conducted immediately following electrical cardioversion.
- Trial name
- AMPEA (NCT06752733)
- Testing
- electrical cardioversion
- Where
- South Korea
- Volunteers
- 160 people
- Sponsor
- Korea University Guro Hospital
Atrial Fibrillation, Arrythmia
Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation
Background: Biphasic truncated exponential (BTE) waveforms are standard for cardiac defibrillation and synchronized cardioversion up to date.
- Conditions
- Atrial Fibrillation, Arrythmia, Electric Countershock
- Trial name
- NCT04032678
- Testing
- Schiller Defigard Touch 7 - DGT7, Schiller Medical, France, LIFEPAK 15, Physio-Control Inc., Redmond, WA, USA
- Where
- Bulgaria
- Volunteers
- 75 people
- Sponsor
- University National Heart Hospital
Atrial Fibrillation
Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study
This is a sequential phase 1 and phase 2 study to evaluate the efficacy of intracardiac echocardiography to detect septal and left atrial pathology as compared to transesophageal echocardiography (Phase 1) and its value in a…
- Trial name
- ICE-CHIP (NCT00281073)
- Testing
- Intra-Cardiac Echocardiography guided Cardioversion, Intracardiac Echo, ICE
- Where
- 6 sites in United States, Netherlands
- Volunteers
- 95 people
- Sponsor
- EP MedSystems
Atrial Fibrillation
Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)
The purpose of the study is to evaluate the efficacy of abbreviated 3-day anticoagulation with dabigatran etexilate before cardioversion guided by trans-oesophageal echocardiography in comparison with conventional 3- week course…
- Trial name
- RE-SOUND (NCT03975062)
- Testing
- dabigatran etexilate
- Where
- Russia
- Volunteers
- 400 people
- Sponsor
- Ural State Medical University
Paroxysmal Atrial Fibrillation
Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation
The purpose of this randomized, double blind, placebo-controlled, superiority clinical trial was to assess clinical efficacy of antazoline in rapid conversion of atrial fibrillation during observation sinus rhythm.
- Trial name
- AnPAF (NCT01527279)
- Testing
- antazoline, 0.9% saline
- Where
- Poland
- Volunteers
- 74 people
- Sponsor
- National Institute of Cardiology, Warsaw, Poland
Atrial Fibrillation
Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation
The aim of this randomized study is to evaluate the efficacy of two different approaches for conversion of persistent atrial fibrillation, the non-invasive one (external electrical cardioversion) and the invasive one (catheter…
- Trial name
- NCT00196209
- Testing
- catheter ablation, external electric cardioversion
- Where
- Germany
- Volunteers
- 130 people
- Sponsor
- Deutsches Herzzentrum Muenchen
Atrial Fibrillation
Dual Versus Single Shock for Cardioversion of Atrial Fibrillation
The investigators aim to investigate the immediate success rate (rate of termination of atrial fibrillation) of dual shock cardioversion compared with standard single shock cardioversion in patients with baseline characteristics…
- Trial name
- NCT03943693
- Testing
- Double shock, Single shock
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- University of Oklahoma
Atrial Fibrillation
Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.
The purpose of this randomized, double blind, non-inferiority clinical trial was to compare the clinical efficacy and safety of antazoline with propafenone in the rapid conversion of paroxysmal non-valvular atrial fibrillation to…
- Trial name
- AnProAF (NCT05720572)
- Testing
- Antazoline, Propafenone
- Where
- Poland
- Volunteers
- 105 people
- Sponsor
- Centre of Postgraduate Medical Education
Persistent Atrial Fibrillation
Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKs
This is a study looking at the feasibility of conducting a larger definitive research trial looking at the effectiveness of high intensity interval training in individuals who are scheduled for electro-cardioversion.
- Trial name
- AFTERSHOCK (NCT03467633)
- Testing
- High-intensity interval training
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Atrial Fibrillation
Heart Rhythm Changes in Patients With Atrial Fibrillation After Cardiopulmonary Bypass: a Retrospective Analysis
The goal of this observational study is to learn about the lthe effect of the tetralogy of medication regimen on intraoperative cardioversion in patients with persistent AF.
- Trial name
- NCT06553391
- Testing
- The tetralogy of medication regimen
- Where
- China
- Volunteers
- 106 people
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital